A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models

A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models

Background Care management of Parkinson’s disease (PD) patients currently remains symptomatic, mainly because diagnosis relying on the expression of the cardinal motor symptoms is made too late. Earlier detection of PD therefore represents a key step for developing therapies able to delay or slow do...

Full description

Bibliographic Details
Main Authors: David Mallet, Thibault Dufourd, Mélina Decourt, Carole Carcenac, Paola Bossù, Laure Verlin, Pierre-Olivier Fernagut, Marianne Benoit-Marand, Gianfranco Spalletta, Emmanuel L. Barbier, Sebastien Carnicella, Véronique Sgambato, Florence Fauvelle, Sabrina Boulet
Format: Article
Language:English
Published: American Society for Clinical Investigation 2022-02-01
Series:The Journal of Clinical Investigation
Subjects:
Metabolism
Neuroscience
Online Access:https://doi.org/10.1172/JCI146400

Internet

https://doi.org/10.1172/JCI146400

Similar Items